The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Abivax SA ADRS 00370M103   15,730,000 1,100,000 SH   SOLE   1,100,000 0 0
ADVERUM BIOTECHNOLOGIES, INC. COMM 00773U108   28,397,928 2,008,340 SH   SOLE   2,008,340 0 0
AEROVATE THERAPEUTICS INC COMM 008064107   65,091,672 2,201,274 SH   SOLE   2,201,274 0 0
AN2 Therapeutics, Inc. COMM 037326105   5,054,134 1,555,118 SH   SOLE   1,555,118 0 0
ASTRIA THERAPEUTICS, INC. COMM 04635X102   74,300,912 5,278,928 SH   SOLE   5,278,928 0 0
C4 THERAPEUTICS, INC. COMM 12529R107   10,429,610 1,276,574 SH   SOLE   1,276,574 0 0
CABALETTA BIO, INC COMM 12674W109   1,480,723 86,795 SH   SOLE   86,795 0 0
CENTESSA PHARMACEUTICALS PLC COMM 152309100   23,061,221 2,040,816 SH   SOLE   2,040,816 0 0
CG ONCOLOGY, INC. COMM 156944100   156,732,043 3,570,206 SH   SOLE   3,570,206 0 0
COGENT BIOSCIENCES INC COMM 19240Q201   41,760,600 6,214,375 SH   SOLE   6,214,375 0 0
COMPASS PATHWAYS PLC ADRS 20451W101   32,098,560 3,858,000 SH   SOLE   3,858,000 0 0
DYNE THERAPEUTICS, INC COMM 26818M108   75,237,759 2,650,150 SH   SOLE   2,650,150 0 0
EDGEWISE THERAPEUTICS, INC. COMM 28036F105   41,454,559 2,272,728 SH   SOLE   2,272,728 0 0
ENTRADA THERAPEUTICS INC COMM 29384C108   8,288,812 584,955 SH   SOLE   584,955 0 0
GERON CORP COMM 374163103   57,392,409 17,391,639 SH   SOLE   17,391,639 0 0
INHIBRX,INC COMM 45720L107   61,193,530 1,750,387 SH   SOLE   1,750,387 0 0
KALVISTA PHARMACEUTICALS, INC COMM 483497103   13,797,402 1,163,356 SH   SOLE   1,163,356 0 0
KEROS THERAPEUTICS, INC. COMM 492327101   58,212,573 879,344 SH   SOLE   879,344 0 0
KODIAK SCIENCES INC COMM 50015M109   4,733,995 899,999 SH   SOLE   899,999 0 0
KURA ONCOLOGY INC COMM 50127T109   30,366,284 1,423,642 SH   SOLE   1,423,642 0 0
MADRIGAL PHARMACEUTICALS INC COMM 558868105   39,864,532 149,283 SH   SOLE   149,283 0 0
MINERALYS THERAPEUTICS, INC. COMM 603170101   41,120,738 3,185,185 SH   SOLE   3,185,185 0 0
NEKTAR THERAPEUTICS COMM 640268108   3,736,800 4,000,000 SH   SOLE   4,000,000 0 0
OCULAR THERAPEUTIX, INC. COMM 67576A100   48,404,247 5,319,148 SH   SOLE   5,319,148 0 0
SAVARA INC. COMM 805111101   49,800,000 10,000,000 SH   SOLE   10,000,000 0 0
SILENCE THERAPEUTICS PLC ADRS 82686Q101   71,179,560 3,295,350 SH   SOLE   3,295,350 0 0
SOLENO THERAPEUTIVS, INC. COMM 834203200   23,540,000 550,000 SH   SOLE   550,000 0 0
STRUCTURE THERAPEUTICS INC ADRS 86366E106   68,508,324 1,598,421 SH   SOLE   1,598,421 0 0
TARSUS PHARMACEUTICALS, INC. COMM 87650L103   28,855,684 793,829 SH   SOLE   793,829 0 0
TOURMALINE BIO INC COMM 89157D105   33,836,880 1,477,593 SH   SOLE   1,477,593 0 0
TYRA BIOSCIENCES INC COMM 90240B106   32,621,289 1,989,103 SH   SOLE   1,989,103 0 0
VENTYX BIOSCIENCES, INC COMM 92332V107   4,486,482 815,724 SH   SOLE   815,724 0 0
VISTAGEN THERAPEUTICS INC COMM 92840H202   14,132,343 2,676,580 SH   SOLE   2,676,580 0 0